CBD does not help glaucoma. In fact, the available evidence suggests CBD could make the condition worse by temporarily raising pressure inside the eye, the very thing glaucoma treatment aims to prevent. Neither the American Academy of Ophthalmology nor the American Glaucoma Society recommends CBD or any cannabis-derived product for glaucoma treatment.
What the Research Actually Shows
The confusion around CBD and glaucoma likely stems from older research on marijuana, which contains both THC and CBD. THC, the compound that produces a high, can lower eye pressure. But CBD is a different molecule with different effects on the eye.
In one of the most cited clinical studies on this topic, researchers gave patients with ocular hypertension or early glaucoma sublingual doses of either THC, CBD, or a placebo. THC lowered eye pressure significantly compared to placebo. CBD did not. A 40 mg dose of CBD actually produced a transient increase in eye pressure at the four-hour mark. That’s the opposite of what a glaucoma patient needs.
This matters because glaucoma damages the optic nerve when pressure inside the eye stays too high for too long. Even a temporary spike in pressure can be harmful over time, especially for someone already at risk of vision loss.
CBD Can Block THC’s Benefits
Here’s something many people don’t realize: CBD can actually cancel out THC’s pressure-lowering effect. CBD has a low affinity for the same receptors in the eye that THC activates to reduce pressure, and it can act as an antagonist at those receptors. In practical terms, this means that using a full-spectrum cannabis product containing both THC and CBD may be less effective at lowering eye pressure than THC alone. The CBD component blunts the very benefit people are hoping to get.
Why THC Isn’t a Good Option Either
Even though THC does lower eye pressure, ophthalmologists don’t recommend it as a glaucoma treatment. The reason comes down to duration. Glaucoma requires consistent, around-the-clock pressure control. In clinical studies, THC’s pressure-lowering effect peaked between 2 and 6 hours after a dose, then faded. To maintain therapeutic pressure levels, a person would need to dose THC every few hours, day and night. That’s not realistic, and the cognitive side effects alone would make normal daily life impossible.
Standard glaucoma treatments, including prescription eye drops and laser procedures, provide steady pressure control without those tradeoffs. They also have decades of evidence showing they preserve vision over the long term.
The Neuroprotection Question
One area that keeps CBD in the conversation is neuroprotection. Glaucoma ultimately damages the retinal ganglion cells, the nerve cells that carry visual information from the eye to the brain. Some preclinical research in animal models has found that CBD can protect retinal cells from damage through anti-inflammatory and antioxidant pathways, reducing harmful compounds that contribute to cell death.
These findings are genuinely interesting. In lab settings, CBD has reduced inflammation markers and protected against nerve cell toxicity in ways that don’t depend on the same receptors involved in eye pressure. It has also shown the ability to reduce breakdown of the blood-retinal barrier in diabetic animals, which points to broader protective properties in the eye.
However, these are all preclinical results from animal studies. No clinical trial in humans has demonstrated that CBD protects the optic nerve in glaucoma patients. The gap between “reduces oxidative stress in a rat model” and “preserves vision in a human with glaucoma” is enormous. And even if CBD did offer some neuroprotective benefit, it would still carry the risk of raising eye pressure, potentially causing more harm than good.
What This Means for You
If you have glaucoma or are at risk for it, replacing or supplementing your prescribed treatment with CBD oil, edibles, or drops is not supported by current evidence. The American Academy of Ophthalmology, the largest association of eye physicians and surgeons in the world, explicitly advises against self-medicating with cannabis products for glaucoma.
The core issue is straightforward: CBD has no demonstrated ability to lower eye pressure in humans, and at least one study found it can raise it. THC does lower pressure, but not long enough to be useful. Products containing both compounds may perform worse than either alone because CBD interferes with THC’s effect on the eye. Meanwhile, proven treatments exist that reliably control pressure 24 hours a day with well-understood side effect profiles.
If you’re currently using CBD for other reasons and also have glaucoma, it’s worth mentioning this to your eye care provider so they can factor it into your pressure readings and overall treatment plan.